Expression of human serum albumin - L7-L12 [Brucella abortus ribosomal protein] fusion protein in Saccharomyces cerevisiae

• Autorzy: Pakzad I , Rezaee A. , Emaneini M. , Hosseini A.Z. , Tabbaraee B. , Taherikalani M.
• Języki publikacji: EN

Abstrakty

EN

Brucella abortus is a facultative intracellular gram-negative bacterial pathogen that causes abortion in pregnant cattle and undulant fever in humans. The immunogenic B. abortus ribosomal protein L7/L12 is a promising candidate antigen for the development of subunit vaccines against brucellosis. It has already been expressed in several bacteria and has been used as DNA vaccine. In order to construct yeast expressing vector for the tHSA-L7/L12 fusion protein, the 171112 ribosomal gene was amplified by PCR. The expression plasmid pYtHSA-L7/Ll 2 was constructed by inserting the L7/L12 gene into the pYHSA5 shuttle vector (containing inulinase signal sequence, HSA gene and Gal 10 promoter). The recombinant vector was transformed into S. cerevisiae and was then induced by galactose. The secreted recombinant fusion protein was detected in supernatant by SDS-PAGE and confirmed by western blot analysis using anti-HSA and anti-L7/L 12 antibodies. Fusion protein was purified by affinity chromatography and its amount was approximately 500 μg/liter.

Słowa kluczowe

EN

serum albumin; man; gene expression; bacteria; Brucella abortus; human disease; brucellosis; zoonosis; Saccharomyces cerevisiae

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2009
• Tom: 58
• Numer: 2
• Strony: 99-104
• Opis fizyczny: p.99-104,fig.,ref.

Twórcy

autor

Pakzad I

• Ilam University of Medical Sciences, Ilam, Iran

autor

Rezaee A.

autor

Emaneini M.

autor

Hosseini A.Z.

autor

Tabbaraee B.

autor

Taherikalani M.

Bibliografia

• Rezaee MA., A. Rezaee, S.M. Moazzeni, Y. Yasuda, K. Tochikubo, S.N. Piraych and M. Arzanlou. 2005. Expression of Escherichia coli heat-labile enterotoxin B subunit (LTB) in Saccharomyces cerevisiae. J. Microbiol. 43: 354-360.
• Baloglu S., S.M. Boyle, R. Vemulapalli, N. Sriranganathan, G. G. Schurig and T.E. Toth. 2005. Immune responses of mice to vaccinia virus recombinants expressing either Listeria monocytogenes partial listeriolysin or Brucella abortus ribosomal L7/L12 protein. Vet. Microbiol. 109: 11-17.
• Cheng HR. and N. Jiang. 2006. Extremely rapid extraction of DNA from bacteria and yeasts. Biotechnol. Lett. 28: 55-59.
• Cheville N.F., M.G. Stevens, A.E. Jensen, F.M. Tatum and S.M. Hailing. 1993. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant Strains of Brucella abortus. Am. J. Vet. Res. 54: 1591-1597.
• Cloeckaert A., N. Vizcaino, J.Y. Paquet, R. Bowden and P.H. Elzer. 2002. Major outer membrane proteins of Brucella spp: past, present and futur. Vet. Microbiol. 90: 229-247.
• Corner L.A. and G.G. Alton. 1981. Persistence of Brucella abortus strain 19 infection in adult cattle vaccinated with reduced doses. Res. Vet. Sci. 31: 342-344.
• Fujiwara S. and T. Amisaki. 2008. Identification of high affinity fatty acid binding sites on human serum albumin by MM-PBSA method. Biophys J. 94: 95-103.
• Hill J., K.A. Donald, D.E. Griffiths and G. Donald. 1991. DMSO enhanced whole cell yeast transformation. Nucleic Acids Res. 19: 57-91.
• Huang L., A.M. Krieg, N. Eller and D.E. Scott. 1999. Induction and regulation of Th 1-inducing cytokines by bacterial DNA, lipopolysaccharid, and heat-inactived bacteria. Infect. Immun. 67: 6257-6263.
• Johnston D. and J.C. Bystryn. 2005. Heterogeneous antibody response to polyvalent melanoma vaccines in syngeneic mice. Cancer Immunol. Immunother. 54: 345-350.
• Jacques I., V. Olivier-Bernardin and G. Dubray. 1991. Induction of antibody and protective responses in mice by brucella O-polysaccharide-BSA conjugate. Vaccine 9: 896-900.
• Jacques M. 1996. Role of lipooligosaccharides and lipopolysaccharide in bacterial adherence. Trends. Microbiol. 4: 408-410.
• Kang HA., E.S. Choi, W.K. Hong, J.Y. Kim, S.M. Ko, J.H. Sohn and S.K. Rhee. 2000. Proteolytic stability of recombinant human serum albumin secreted in the yeast Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol. 53: 575-582.
• Ko J. and Splitter A.G. 2003. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and human. Clin. Microbiol. Rev. 16: 65-78.
• Kurar E. and G.A. Splitter. 1997. Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune response. Vaccine 15: 1851-1857.
• Moreno E., I. Moriyon. and A. Cloeckaert. 2002. Brucella evolution and taxonomy. Vet. Microbiol. 90: 209-227.
• Moriyon I., M.J. Grillo, D. Monreal, D. Gonzalez, C. Marin, I. Lopez-Goni, R.C. Mainar-Jaime, E. Moreno and J.M. Blaseo. 2004. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet. Res. 35: 1-38.
• Oliveira S. C. and G.A. Splitter. 1994. Subcloning and expression of the Brucella abortus L7/L12 ribosomal gene and T-lymphocyte recognition of the recombinant protein. Infect. Immun. 62: 5201-5204.
• Oliveira S. C. and G.A. Splitter. 1995. CD8_ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice. Eur. J. Immunol. 25: 2551-2557.
• Oliveira S.C. and G.A. Splitter. 1996. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14: 959-962.
• Oliveira S.C., Y. Zhu and G.A. Splitter. 1994. Recombinant L7/L12 ribosomal protein and gamma-irradiated Brucella abortus induce a T-helper 1 subset response from murine CD4_ T cells. Immunology 83: 659-664.
• Onate A.A., R. Vemulapalli, E. Andrews, G.G. Schurig, S. Boyle and H. Folch. 1999. Vaccination with live Escherichia coli expressing Brucella abortus Cu/Zn superoxide dismutase protects mice against virulent B. abortus. Infect. Immun. 67: 986-988.
• Pines, O., and A. London. 1991. Expression and secretion of Staphylococcus nuclease A in yeast: effects of amino terminal sequences. J. Gen. Microbiol. 137: 771-778.
• Pines, O., C.A. Lunn, and M. Inouye. 1988. Defective E. coli signal peptidase function in yeast. Mol. Microbiol. 2: 209-217.
• Pontes, D. S., F. A. Dorella, L. A. Ribeiro, A. Miyoshi, Y. Le Loir, A. Gruss, S. C. Oliveira, P. Langella, and V. Azevedo. 2003. Induction of partial protection in mice after oral administration of Lactococcus lactis producing Brucella abortus L7/L12 antigen. J. Drug Target. 11: 489-493.
• Ribeiro L.A., V. Azevedo, Y. Le Loir, S.C. Oliveira, Y. Dieye, J.C. Piard, A. Gruss and P. Langella. 2002. Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis. Appl. Environ. Microbiol. 68: 910-916.
• Schirmbeck R., M. Kwissa, N. Fissolo, S. Elkholy, P. Riedl and J. Reimann. 2002. Priming polyvalent immunity by DNA vaccines expressing chimeric antigens with a stress protein-capturing, viral J-domain. FASEB J. 16: 1108-1110.
• Schurig G.G., J.M. Corbel and N. Sriranganathan. 2002. Brucellosis vaccine: past, present and future. Vet. Microbiol. 90: 479-496.
• Vemulapalli R., Y. He, S. Cravero, N. Sriranganathan, S.M. Boyle and G.G. Schurig. 2000. Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51. Infect.Immun. 68: 3286-3289.
• Vizcaino N., A. Cloeckaert, G. Dubray and M.S. Zygmunt. 1996. Cloning nucleotide sequence and expression of the gene coding for a ribosome releasing factor homologous protein of Brucella melitensis. Infect. Immun. 64: 4834-4837